zur Startseite
Dates
Thursday,

Veranstaltung

Veranstalter, Ort
News/Publications

Plain Language Summary of the Innovate Study: Ibrutinib Plus Rituximab Is Well-Tolerated and Effective in People with Waldenström's Macroglobulinemia

Buske, C., A. Tedeschi, J. Trotman, R. García-Sanz, D. MacDonald, V. Leblond, B. Mahe, C. Herbaux, J. V. Matous, C. S. Tam, L. T. Heffner, M. Varettoni, M. L. Palomba, C. Shustik, E. Kastritis, S. P. Treon, J. Ping, B. Hauns, I. Arango-Hisijara, and M. A. Dimopoulos. Future Oncol (Feb 23 2023).
read more ›
 
 

Privacy Policy

Privacy Policy (Datenschutz)

 

Please note that the Privacy Policy of the Uniklinik Ulm applies.

 


For further information please contact doris.jehle@uniklinik-ulm.de